PRF Technologies Ltd.
PRF Technologies Ltd. is a U.S.-listed company with two operating lines: a pharmaceutical development business focused on reformulating established therapeutics, and a software business built around its DeepSolar platform for AI-driven energy optimization. The company’s technology footprint includes the GridFeed and DeepSolar Predict offerings, which are used in renewable-energy forecasting, trading support, and performance optimization, alongside pharmaceutical programs using an extended-release drug-delivery system.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaPrograms to reformulate established therapeutics using proprietary drug-delivery systems.
AI-based software for forecasting, monitoring, and optimizing energy use and production.
GridFeed tools for market participation, trading support, and revenue optimization.
Asiakkaat
PRF serves two very different customer groups: healthcare stakeholders interested in reformulated therapeutics and extended-release drug delivery, and renewable-energy participants needing forecasting and market decision tools. On the energy side, the company targets solar asset owners, operators, investors, traders, balancing responsible parties, and other market participants that need better visibility into production and price dynamics.
Buy forecasting, analytics, and optimization tools to improve solar performance and reduce imbalance costs.
Use GridFeed for day-ahead and intraday trading decisions and revenue optimization.
Use DeepSolar analytics for technical due diligence, performance review, and risk assessment.
Support development and potential commercialization of reformulated therapeutic candidates.
Strategia
PRF is building a dual-track business that combines pharmaceutical reformulation with AI-enabled energy software, giving it exposure to both life sciences and renewable-energy workflows. Near term, the company is focused on advancing clinical development while commercializing DeepSolar through customer meetings, partnerships, and broader deployment of GridFeed in energy trading and optimization.
Clinical progress is needed to create optionality in the pharmaceutical pipeline and support long-term value creation.
European energy trading is a concrete target market where the company can win early adopters for its AI tools.
Moving from forecasting to trading and revenue optimization expands the platform's value proposition and addressable use cases.
Maantiede
The company is U.S.-listed, but its reported operating footprint is international, with a disclosed base in Tel Aviv, Israel and commercial activity aimed at European energy markets. Its DeepSolar business is being presented to market participants in Europe, while the pharmaceutical programs are described through U.S.-based clinical development and reporting structures.
Riskit
PRF faces the execution risks of a diversified early-stage company: clinical-development uncertainty in pharmaceuticals and adoption risk in a nascent software platform. It also has listing and financing risk, since management has disclosed the importance of meeting Nasdaq continued-listing standards and the business depends on external funding and partner traction.
- Funding and dilution riskVaikutus: KorkeaTodennäköisyys: Korkea
Early-stage development and commercialization typically require ongoing external capital.
Kohdistuu: Equity issuance and warrant overhang
- Nasdaq continued listing complianceVaikutus: KorkeaTodennäköisyys: Kohtalainen
The company disclosed risk of delisting if it fails minimum bid price, equity, or market value requirements.
Kohdistuu: Ordinary shares and capital-market access
- Clinical development failureVaikutus: KorkeaTodennäköisyys: Kohtalainen
Pharmaceutical candidates depend on trial execution and regulatory outcomes that can be delayed or negative.
Kohdistuu: OcuRing™-K and reformulation pipeline
- Commercial adoption risk for DeepSolarVaikutus: KeskitasoTodennäköisyys: Korkea
The platform is still being introduced to customers and partners, so revenue conversion depends on market acceptance.
Kohdistuu: GridFeed and AI energy software
Kirjanpito
Harkinnanvaraiset erätThe company noted changes in valuation allowance on tax losses and other deferred tax assets.
Vaikutus: Can materially change reported tax expense and equity
Management must estimate interest and penalties tied to unrecognized tax positions.
Vaikutus: Affects tax expense and contingency disclosures
Options, warrants, and prefunded warrants can affect the denominator when dilutive.
Vaikutus: Affects per-share comparability and dilution analysis
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Propanc Biopharma, Inc.
PPCB · Pharmaceutical Preparations
GridAI Technologies Corp.
GRDX · Electric & Other Services Combined
Hyperfine, Inc.
HYPR · Electromedical & Electrotherapeutic Apparatus
Brookfield Renewable Partners L.P.
BEP · Electric Services
RenovoRx, Inc.
RNXT · Surgical & Medical Instruments & Apparatus
Brookfield Renewable Corp
BEPC · Electric Services
Brookfield Renewable Corp is a New York-headquartered holding company that gives investors exposure to Brookfield Renewable’s portfolio of renewable power and sustainable solutions assets.
Päivitetty: 28.9.2026